(Q37866754)

English

Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries

scientific article published on May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

gastroenteritis

1 reference

based on heuristic

inferred from title

rotavirus vaccine

1 reference

based on heuristic

inferred from title

1

object named as

Greg L Plosker

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

439-454

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Global Illness and Deaths Caused by Rotavirus Disease in Children

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus gastroenteritis.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Vaccines for rotavirus gastroenteritis universally needed for infants

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus and severe childhood diarrhea

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Burden of rotavirus disease in European Union countries

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Protective effects of natural rotavirus infection

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

The impact of rotavirus gastroenteritis on the family

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Rotavirus vaccines in Belgium: policy and impact

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Real-world impact of rotavirus vaccination

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

The future of rotavirus vaccines: a major setback leads to new opportunities

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy).

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

The cost-effectiveness of rotavirus vaccination in Australia

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysis

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

What is the price of life and why doesn't it increase at the rate of inflation?

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Cost and cost-effectiveness of childhood vaccination against rotavirus in France

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Coïncidence des épidémies de rotavirus et de virus respiratoire syncytial à Paris: 12 ans de surveillance

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds

1 reference

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

Assessing the introduction of universal rotavirus vaccination in the Netherlands

2 references

https://api.crossref.org/works/10.2165%2F11207130-000000000-00000

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus activity-- United States, July 2007-December 2008.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finland introduces rotavirus vaccine into the national vaccination programme in September 2009

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Nosocomial infections due to rotavirus and respiratory syncytial virus in pediatric wards: a 2-year study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of influenza

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic analysis of rotavirus vaccination in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/21504245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11207130-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37866754&oldid=2201211266"